Thread: WATCH: IVERMECTIN & HYDROXYCHLOROQUINE DEFINITELY WORK | 08-17-2021

we warned and warned

Thread: Whistleblower: Remdesivir treatments have killed 601 service members | 10/11/2024

Ivermectin Can't Be Stopped (Video)

Ivermectin Can't Be Stopped (Video)

Friday, October 18, 2024 0:27
by N.Morgan

Video zn21g5kls-n995.bitchute.com/rCV33V10lLJ0/UdBmKfS0ZrHf.mp4

New research debunks cardiac safety SMEAR CAMPAIGN waged against Hydroxychloroquine combination therapy

12/20/2024 // Lance D Johnson // 90 Views

Tags: alternative medicine, azithromycin, cardiac safety, Censorship, COVID-19 treatments, effective treatment protocol, goodhealth, goodmedicine, goodscience, hcq, medical ethics, medical fascism, Medical Tyranny, pandemic, real investigations, remdesivir, research, scientific integrity, smear campaign, Suppressed, truth, vitamin C, vitamin D, zinc

• New research debunks cardiac safety concerns of Hydroxychloroquine (HCQ) combined with Azithromycin, Vitamin C, Vitamin D, and Zinc.
  
  
• Despite the protocol being vilified, the ProgenaBiome study finds no significant cardiac risks in critically ill COVID-19 patients treated with this protocol.
  
  
• Utilizing continuous EKG monitoring and statistical analysis, the study concludes that the protocol is a safe and viable option for COVID-19 treatment.
  
  
• The research challenges the suppression of alternative COVID-19 treatments, citing controversies and unethical retraction of previous studies on HCQ and Azithromycin.
  
  
• Bio-pharmaceutical interests prioritize profit over public health, promoting more expensive mRNA vaccines.
  
  
• Study urging stakeholders to prioritize evidence-based policies and accessible treatments.
  
  

HCQ, azithromycin, vitamin C & D, and zinc proven safe again
In a stunning revelation that challenges the prevailing narrative on COVID-19 treatments, new research published in the journal BMC Cardiovascular Disorders has definitively debunked concerns over the cardiac safety of Hydroxychloroquine paired with Azithromycin, Vitamin C, Vitamin D, and Zinc (HAZDPac). The ProgenaBiome study, conducted by a team of esteemed researchers including Sabine Hazan, Adriana C. Vidal, Nicolas Hulscher, Amelia Goudzwaard, Peter A. McCullough, and Alon A. Steinberg, provides crucial evidence that this combination therapy does not pose significant cardiac risks.

The present study, a Phase II Double-Blind Randomized Placebo-Controlled Trial, meticulously monitored 83 critically ill COVID-19 patients over a 10-day period. Patients receiving HAZDPac treatment showed no significant prolongation of the QTc interval compared to those on placebo. This finding is particularly significant because concerns over QTc interval prolongation have been a major obstacle in the use of Hydroxychloroquine for COVID-19 treatment.

The research design employed continuous EKG monitoring, enabling the team to gather highly accurate data. Utilizing two-sample t-tests, the researchers analyzed QTc intervals recorded from patients in the treatment group and those on placebo, with no significant differences observed. The study's conclusion is unequivocal: HAZDPac, a potent combination therapy, remains a safe and viable option for treating COVID-19, and its use does not lead to cardiac complications.

The findings are particularly noteworthy in light of the ongoing ethical debates surrounding the suppression of alternative COVID-19 treatments. One such controversial episode involves the retraction of a landmark study on Hydroxychloroquine and Azithromycin published by the same research team. This study had been widely cited by 6,713 scientists and researchers over four years before being unjustly removed from circulation. Such retraction raises serious questions about the integrity of scientific inquiry and the motivations behind such actions.

Bio-pharmaceutical complex conspires to shut down, vilify, and retract studies on helpful treatments for COVID-19
The retraction, dubbed an act of "unethical suppression" by the research community, is seen as part of a broader strategy by biopharmaceutical interests to prioritize profit over public health. "The Biopharmaceutical Complex," as some critics have called it, is accused of systematically downplaying or censoring evidence that might support the use of cheaper, safer, and more accessible treatments like Hydroxychloroquine. The smear campaign against HCQ, for instance, led to publications claiming that HCQ caused 17,000 deaths. This was exposed as fraud. This strategy made way for the promotion of more expensive mRNA vaccines and remdesivir, pushed onto patients under emergency use authorization.

Despite the significant challenges faced, the authors of this study remain steadfast in their commitment to scientific truth and public health. "We will continue to conduct, support, and disseminate high-quality research," stated Professor Peter A. McCullough, a key figure in the research community. "It is our duty to uphold scientific integrity and ensure that effective treatments reach those who need them."

The implications of these findings are profound. Not only do they suggest that hydroxychloroquine is safe for outpatient use, but they also challenge the market dynamics that have governed the response to the pandemic. If Hydroxychloroquine proves to be an effective and accessible treatment, the implications for global health policies and the affordability of care could be profound.

As the research community continues to grapple with ethical and scientific challenges in the wake of the pandemic, the ProgenaBiome study stands as a powerful testament to the resilience of scientific inquiry and the undying commitment to truth and public welfare. It is a call to action for all stakeholders to reevaluate their priorities and ensure that the search for effective treatments is driven by evidence, not by the dictates of commercial interests.

Sources include:
PeterMcCulloughMD.substack.com
BMC.Biomedcentral.com
ScienceDirect.com
PeterMcCulloughMD.substack.com
NaturalNews.com

New research debunks cardiac safety SMEAR CAMPAIGN waged against Hydroxychloroquine combination therapy – NaturalNews.com

Ivermectin cures Cancer

Thread: Clif High: Trust Me, Deep State Has Fallen! GITMO Awaits! (Video) Greg Hunter

HYDROGEN PEROXIDE (H2O2) KILLS GERMS AND CANCER CELLS JUST BY RUBBING IT ON

HYDROGEN PEROXIDE (H2O2) KILLS GERMS AND CANCER CELLS JUST BY RUBBING IT ON

• WATCH

ABC’s covert promotion of killer drug REMDESIVIR in TV show sparks legal firestorm

Thread: ABC’s covert promotion of killer drug REMDESIVIR in TV show sparks legal firestorm 07

Ivermectin cuts malaria cases by 26% in Kenyan children, proving its safety and efficacy while exposing media lies

07/31/2025 // Cassie B. // 260 Views

Tags: covid-19, deception, health, health freedom, ivermectin, lifesaving drug, Malaria, media, mosquito, propaganda, World Health Organization

• A new study shows that ivermectin reduces malaria cases by 26% in Kenyan children, proving its safety and effectiveness.
• The trial involved 20,000 participants and found that ivermectin kills malaria-carrying mosquitoes when they bite treated individuals.
• Health agencies and the media falsely labeled ivermectin as dangerous during COVID-19, despite its Nobel Prize-winning safety record.
• Mosquito resistance to insecticides makes ivermectin a crucial new tool in malaria prevention.
• The study exposes past misinformation while highlighting ivermectin’s potential to save lives globally.

A groundbreaking study published in the New England Journal of Medicine has confirmed that mass ivermectin administration slashes malaria cases by 26% among Kenyan children without severe side effects.
The randomized trial, involving more than 20,000 participants, demonstrates that the anti-parasitic drug kills malaria-carrying mosquitoes when they feed on treated individuals, offering a powerful new tool against a disease that claims nearly 600,000 lives annually. This revelation exposes the hypocrisy of government health agencies and their allies, who falsely smeared ivermectin as "dangerous" during the COVID-19 pandemic while suppressing its proven, life-saving benefits.
The study that silenced the skeptics

The BOHEMIA trial, led by the Barcelona Institute for Global Health (ISGlobal), administered ivermectin (400 mcg/kg) monthly for three months to communities in Kwale County, Kenya—a region with high malaria transmission and widespread bed net use. The results were undeniable: children in the ivermectin group saw a 26% reduction in malaria infections compared to the control group given albendazole.
"We are thrilled with these results," said Dr. Carlos Chaccour, co-principal investigator of the study. "Ivermectin has shown great promise in reducing malaria transmission and could complement existing control measures. With continued research, ivermectin MDA could become an effective tool for malaria control and even contribute to elimination efforts."
No severe adverse effects were reported, dismantling the myth that ivermectin is unsafe—a lie perpetuated by the Biden administration and its media lapdogs when Americans sought the drug as a COVID-19 treatment.
Media and government deception exposed

During the pandemic, ivermectin was demonized as a "horse dewormer" by outlets like CNN and the Washington Post, while the FDA absurdly warned Americans not to use it despite its Nobel Prize-winning history as a safe human medicine. Meanwhile, Big Pharma pushed expensive, ineffective vaccines and remdesivir, a drug with deadly side effects.
Now, the same drug they mocked is proving to be a malaria game-changer. "This research has the potential to shape the future of malaria prevention," said Dr. Regina Rabinovich, director of ISGlobal’s Malaria Elimination Initiative.
The study’s findings align with the World Health Organization’s (WHO) criteria for new malaria interventions, yet the same global health bodies that dismissed ivermectin for COVID-19 are now forced to acknowledge its lifesaving potential.
A weapon against insecticide resistance

Malaria control is in crisis. Mosquitoes have grown resistant to insecticides used in bed nets and indoor sprays, rendering traditional tools less effective. Ivermectin offers a novel solution: when mosquitoes bite treated individuals, the drug kills them, breaking the transmission cycle.
Beyond malaria, ivermectin delivered unexpected public health wins, reducing scabies, lice, and bed bug infestations in treated communities. Yet while Africa reaps these benefits, Western elites continue suppressing the drug to protect pharmaceutical profits.
The same media that smeared ivermectin is now ignoring this study. Why? Because it exposes their COVID-era propaganda as a fraud.
Science has vindicated ivermectin... again. While corrupt governments and media lied, real-world evidence proves its safety and efficacy. This study isn’t just a malaria breakthrough; it’s a damning indictment of the medical tyranny that denied patients access to a lifesaving drug.
The question now is whether the WHO, CDC, and FDA will apologize for their deadly deception. Don’t hold your breath!
Sources for this article include:
TheEpochTimes.com
Cidrap.UMN.edu
SciTechDaily.com
ScienceDaily.com

Ivermectin cuts malaria cases by 26% in Kenyan children, proving its safety and efficacy while exposing media lies – NaturalNews.com